: CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.

The deubiquitinase activity of CYLD is required for B cell differentiation / Pseftogas, A., Bordini, J., Gavriilidis, G., Frenquelli, M., Campanella, A., Rovida, A., Morello, G., Gerousi, M., Theodosiou, E., Fragkouli, S., Vasileiou, V., Sklaviadis, T., Dafou, D., Mosialos, G., Tripodo, C., Psomopoulos, F., Winkler, T.H., Stamatopoulos, K., Ghia, P., Xanthopoulos, K.. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - 17:1(2026). [10.1038/s41419-026-08555-x]

The deubiquitinase activity of CYLD is required for B cell differentiation

Bordini, Jessica
Secondo
;
Campanella, Alessandro;Rovida, Alessandra;Ghia, Paolo
Penultimo
;
2026-01-01

Abstract

: CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream-875061357.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 5.38 MB
Formato Adobe PDF
5.38 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/200677
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact